GANX

Gain Therapeutics, Inc.

1.86 USD
-0.03 (-1.59%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Gain Therapeutics, Inc. stock is down -29.01% since 30 days ago. The next earnings date is Aug 8, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 25% of the previous 3 June’s closed higher than May. 100% of analysts rate it a buy.

About Gain Therapeutics, Inc.

Gain Therapeutics, Inc. engages in developing therapies to treat diseases caused by protein misfolding. It focuses on rare genetic diseases and neurological disorders. The company was founded in 2017 and is based in Bethesda, Maryland.

  • HC Wainwright & Co.
    Fri May 31, 06:17
    buy
    confirm
  • HC Wainwright & Co.
    Tue May 28, 06:32
    buy
    confirm